Department of Physiology.
Cystic Fibrosis Translational Research Center.
Am J Respir Cell Mol Biol. 2023 Sep;69(3):281-294. doi: 10.1165/rcmb.2022-0241OC.
CFTR (cystic fibrosis transmembrane conductance regulator) is a tightly regulated anion channel that mediates chloride and bicarbonate conductance in many epithelia and in other tissues, but whether its regulation varies depending on the cell type has not been investigated. Epithelial CFTR expression is highest in rare cells called ionocytes. We studied CFTR regulation in control and ionocyte-enriched cultures by transducing bronchial basal cells with adenoviruses that encode only or (forkhead box I1) + as separate polypeptides. FOXI1 dramatically increased the number of transcripts for ionocyte markers (Achaete-Scute Family BHLH Transcription Factor 3), , , , , and without altering those for secretory (), basal (, , ), goblet (), or ciliated () cells. The number of cells displaying strong FOXI1 expression was increased 7-fold, and there was no evidence for a broad increase in background immunofluorescence. Total mRNA and protein levels increased 10-fold and 2.5-fold, respectively. Ionocyte-enriched cultures displayed elevated basal current, increased adenylyl cyclase 5 expression, and tonic suppression of CFTR activity by the phosphodiesterase PDE1C, which has not been shown previously to regulate CFTR activity. The results indicate that CFTR regulation depends on cell type and identifies PDE1C as a potential target for therapeutics that aim to increase CFTR function specifically in ionocytes.
CFTR(囊性纤维化跨膜电导调节因子)是一种紧密调节的阴离子通道,可介导许多上皮细胞和其他组织中的氯离子和碳酸氢根离子电导,但 CFTR 的调节是否因细胞类型而异尚未得到研究。上皮 CFTR 的表达在称为离子细胞的稀有细胞中最高。我们通过用编码仅 或 (叉头框 I1)+ 的腺病毒转导支气管基底细胞来研究对照和富含离子细胞的培养物中的 CFTR 调节,作为单独的多肽。FOXI1 显着增加了离子细胞标志物 (Achaete-Scute Family BHLH Transcription Factor 3)、 、 、 、和 的转录物数量,而不改变分泌细胞()、基底细胞(、、)、杯状细胞()或纤毛细胞()的转录物。显示强烈 FOXI1 表达的细胞数量增加了 7 倍,并且没有证据表明背景免疫荧光广泛增加。总 mRNA 和蛋白水平分别增加了 10 倍和 2.5 倍。富含离子细胞的培养物显示出基础电流增加、腺苷酸环化酶 5 表达增加以及磷酸二酯酶 PDE1C 的 CFTR 活性持续抑制,以前尚未显示 PDE1C 调节 CFTR 活性。结果表明,CFTR 的调节取决于细胞类型,并确定 PDE1C 是一种潜在的治疗靶点,旨在特异性增加离子细胞中的 CFTR 功能。